Antibiotic Use and Safety

Introduction to Antibiotic Safety

The use of fluoroquinolones, including levofloxacin, should be avoided during pregnancy due to potential risks to the fetus, and alternative antibiotics should be used whenever possible, as recommended by the American College of Physicians and other guideline societies 1, 2
The Centers for Disease Control and Prevention and other guideline societies recommend using safer alternative antibiotics, such as ampicillin, cefotaxime, ceftriaxone, or TMP-SMZ, as first-line options for treating infections during pregnancy 1, 2

Quinolones are contraindicated in children and adolescents due to the risk of cartilage damage and arthropathy, as stated by the American Pediatrics Society 3
Ciprofloxacin is contraindicated in pediatric patients under 18 years, except for specific FDA-approved indications, such as complicated UTIs, pyelonephritis due to E. coli, and post-exposure treatment for inhalation anthrax, as recommended by the American Academy of Pediatrics 3
Elderly patients are at higher risk of adverse effects, including tendinopathy, CNS toxicity, and QT prolongation, due to age-related changes in pharmacokinetics and polypharmacy 4
Risk factors for adverse effects include age >60 years, renal impairment, concomitant corticosteroid use, and pre-existing CNS disorders, which should be carefully evaluated before initiating ciprofloxacin therapy 4

Fluoroquinolones can cause arthropathy and osteochondrosis in juvenile animals, and there is a risk of QT prolongation, tendinopathy, CNS toxicity, and other adverse effects in humans 1, 2
The following adverse effects can occur:

Patients receiving fluoroquinolone prophylaxis should not receive oral empirical therapy with a fluoroquinolone, as recommended by the Infectious Diseases Society of America 6
If fluoroquinolones are absolutely necessary, they should only be used when the potential benefit justifies the potential risk to the fetus, and a detailed fetal ultrasound examination should be considered 1
Ciprofloxacin should be avoided during pregnancy due to potential teratogenic effects, as advised by the Centers for Disease Control and Prevention 7
A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother, as levofloxacin is excreted in human milk 1
Most sources recommend avoiding fluoroquinolones during breastfeeding if possible, due to potential risks of arthropathy and cartilage damage in the infant 1, 2

Dose adjustment is required based on creatinine clearance, with specific guidance needed for elderly patients with impaired renal function 4
Monitoring is necessary, including regular assessment of renal function, electrolytes, and clinical response, to minimize the risk of adverse effects 4
The European Urology guidelines recommend using the lowest effective dose based on indication and renal function, and monitoring for early signs of adverse effects, particularly confusion, tendon pain, or cardiac symptoms 4
Ensuring adequate hydration to prevent crystalluria and avoiding concomitant medications that increase risk (corticosteroids, QT-prolonging drugs) are also crucial, as emphasized by the European Urology guidelines 4

Quinolones can interact with other medications, including theophylline, antiarrhythmic agents, corticosteroids, and antacids, which can increase the risk of adverse effects, such as convulsions, QT interval prolongation, and tendinopathy 5
Quinolones should be reserved for specific situations where no safe and effective alternatives exist, due to their potential for adverse effects and the increasing risk of microbial resistance, as recommended by the American Pediatrics Society 3
Ciprofloxacin should be reserved for specific approved indications or life-threatening infections with multidrug-resistant organisms when no alternatives exist in pediatric patients, as advised by the American Academy of Pediatrics 3